wsnewspublishers PlasmaTech Biopharmaceuticals, declared that it closed the formerly declared equity financing of $10 million of common stock at a price of $8.00 per share, or 1,250,000 shares, and warrants to purchase 625,000 shares of common stock. The warrants have … |
![](https://i0.wp.com/commonstockwarrants.com/wp-content/uploads/2015/05/143189-thumb.jpg?fit=80%2C80&ssl=1)